T-CELL RESPONSE AFTER COVID-19 VACCINE IS NOT IMPAIRED BY EARLY RITUXIMAB TREATMENT OR BELIMUMAB IN SYSTEMIC AUTOIMMUNE DISORDERS

被引：0
|
作者：
De Marchi, G. [1 ]
Fabris, M. [2 ]
Domenis, R. [2 ]
Guella, S. [2 ]
Cabas, N. [1 ]
Caponnetto, F. [2 ]
Beltrami, A. P. [2 ]
De Vita, S.
Curcio, F. [2 ]
Quartuccio, L. [1 ]
机构：
[1] Dept Med, Div Rheumatol, Udine, Italy
[2] Inst Pathol, Dept Med, Udine, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1786
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0174
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients
    Fabris, Martina
    De Marchi, Ginevra
    Domenis, Rossana
    Caponnetto, Federica
    Guella, Silvia
    Dal Secco, Chiara
    Cabas, Nicola
    De Vita, Salvatore
    Beltrami, Antonio Paolo
    Curcio, Francesco
    Quartuccio, Luca
    JOURNAL OF AUTOIMMUNITY, 2022, 129
  • [2] Rituximab Impairs B Cell Response But Not T Cell Response to COVID-19 Vaccine in Autoimmune Diseases
    Bitoun, Samuel
    Henry, Julien
    Desjardins, Delphine
    Vauloup-Fellous, Christelle
    Dib, Nicolas
    Belkhir, Rakiba
    Mouna, Lina
    Joly, Candie
    Bitu, Marie
    Ly, Bineta
    Pascaud, Juliette
    Seror, Raphaele
    Afonso, Anne-Marie Roque
    Le Grand, Roger
    Mariette, Xavier
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 (06) : 927 - 933
  • [3] COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial
    Abbasi, Jennifer
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (02): : 115 - 115
  • [4] Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients
    Avishai Maliah
    Roma Parikh
    Oshrat E. Tayer-Shifman
    Oded Kimhi
    Raz Gepstein
    Tami Halperin
    Yair Levy
    Carmit Levy
    Yael Pri-Paz Basson
    Shaye Kivity
    Scientific Reports, 12
  • [5] Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients
    Maliah, Avishai
    Parikh, Roma
    Tayer-Shifman, Oshrat E.
    Kimhi, Oded
    Gepstein, Raz
    Halperin, Tami
    Levy, Yair
    Levy, Carmit
    Basson, Yael Pri-Paz
    Kivity, Shaye
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] EVALUATING THE EFFICACY OF THE COVID-19 BOOSTER VACCINE IN PRODUCING AN EFFECTIVE T-CELL RESPONSE
    Barve, A.
    Cortazar, J.
    Mallon, P. W. G.
    Kenny, G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (SUPPL 1) : S24 - S25
  • [7] Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine
    Gaignard, Marie-Estelle
    Lieberherr, Sven
    Schoenenberger, Andreas
    Benz, Rudolf
    HEMASPHERE, 2021, 5 (08): : E618
  • [8] COVID-19 vaccine literacy in patients with systemic autoimmune diseases
    María Correa-Rodríguez
    Blanca Rueda-Medina
    José-Luis Callejas-Rubio
    Raquel Ríos-Fernández
    Javier de la Hera-Fernández
    Norberto Ortego-Centeno
    Current Psychology, 2023, 42 : 13769 - 13784
  • [9] COVID-19 vaccine literacy in patients with systemic autoimmune diseases
    Correa-Rodriguez, Maria
    Rueda-Medina, Blanca
    Callejas-Rubio, Jose-Luis
    Rios-Fernandez, Raquel
    de la Hera-Fernandez, Javier
    Ortego-Centeno, Norberto
    CURRENT PSYCHOLOGY, 2023, 42 (16) : 13769 - 13784
  • [10] COVID-19 vaccine-associated autoimmune disorders: Comments
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2023, 4 (01): : 46 - 46
12345